Luxxu Group Limited 2025 Annual Report: In-Depth Analysis for Investors

Executive Summary

Luxxu Group Limited (“the Group”), a Hong Kong-based investment holding company with operations in the manufacturing, trading, and retailing of branded watches and jewellery, as well as exhibition services, has released its 2025 Annual Report. The company has shown improvement in reducing its annual loss, strengthened its liquidity, and taken key steps in capital restructuring. However, challenges remain, particularly in trade receivable recovery and ongoing operational losses.

Key Financial Highlights

• Loss Reduction: Annual loss narrowed to RMB21.7 million for FY2025, down from RMB52.0 million in 2024 – a significant improvement, but the company remains unprofitable.
• Cash Position: Total cash and bank balances increased to RMB4.2 million (2024: RMB1.0 million), indicating improved liquidity.
• Current Ratio: Improved from 5.7x to 7.3x, highlighting stronger short-term liquidity.
• Gearing Ratio: Reduced from 86.2% to 82.0%, reflecting lower leverage but still at a high level relative to equity.
• Trade Receivables & ECL: Net trade receivables stand at RMB7.98 million after a substantial allowance for expected credit losses (ECL) of RMB62.2 million, suggesting ongoing collection challenges and significant credit risk exposure.
• No Dividend: The Board did not recommend any final dividend for 2025 (nor for 2024).

Significant Corporate Developments

• Capital Reorganisation & Rights Issue:
  • In March 2025, the company completed a capital reorganisation, consolidating every five shares into one, followed by a capital reduction and share subdivision.
  • In May 2025, a rights issue raised approximately HK\$16.06 million (net), boosting capital and liquidity. Share capital structure now consists of 215,654,400 shares with a par value of HK\$0.01 each.
• Investment Portfolio:
  • Significant investments in listed entities such as BFB Health Limited (1.4% equity interest; RMB10.5 million, 20.2% of group assets), AMCO, and CAPITAL. These investments are marked to market and subject to equity price risk.
  • The Group’s price risk sensitivity analysis suggests that a 15% move in stock prices could impact pre-tax loss by RMB3.51 million.
• Impairment and Receivables Concerns:
  • High allowance for ECL on trade receivables (RMB62.2 million), with the majority of overdue balances over 180 days (ECL rate: 92.3%). Collection of these receivables remains a critical risk.
• No Material Acquisitions/Disposals: No major M&A activity in 2025.

Operational and Strategic Updates

• Principal Business: Manufacture, trading, and retail of branded and OEM watches and jewellery, as well as exhibition services.
• Revenue Concentration: Largest customer accounts for 14% of revenue; top five customers make up 55%. Supplier concentration is similar, raising counterparty risk considerations.
• Employees: Workforce reduced from 56 to 51; annual remuneration expense of RMB5.0 million, reflecting efficiency efforts.
• ESG & Compliance: No material non-compliance with laws and regulations. Strong focus on sustainability, waste reduction, and resource efficiency.

Risk Factors and Governance

• Major Risks: Market volatility, industry competition, customer demand shifts, liquidity, credit, currency, and price risks.
• Internal Controls: The company maintains multi-layered investment controls and regular internal audits. The Audit Committee, comprised solely of independent non-executive directors, actively reviews control and risk systems.
• Shareholder Structure: The company maintains a public float over 25% as required by the Hong Kong Stock Exchange.
• Share Option Scheme: As of end-2025, 6.065 million share options outstanding. If exercised, these could dilute existing shareholders further.

Matters Potentially Affecting Share Value

• Improved Loss Position: The Group’s substantial reduction in net loss could be seen as a positive sign of progress towards profitability, supporting a potential share price re-rating if sustained.
• Capital Raising and Restructuring: The successful capital reorganisation and rights issue strengthen the balance sheet, improve liquidity, and may facilitate future growth or debt reduction, all of which can be share-price accretive.
• Receivables Risk: The large provision for bad debts and the high proportion of overdue receivables (especially those overdue by more than 180 days) remain a significant risk. If collection efforts do not improve, this could pressure future results and valuations.
• Equity Market Exposure: The size and volatility of the Group’s investments in listed securities could introduce earnings volatility, directly impacting future profits and share value depending on market performance.
• Ongoing Lack of Dividend: Continued suspension of dividend payments may deter income-focused investors and could affect share demand.

Outlook

The Board and management remain optimistic, focusing on resource efficiency, risk control, and seeking new opportunities. The Group’s strengthened liquidity and reduced losses provide a foundation for recovery. However, significant challenges persist in receivable collection and maintaining profitability. Shareholders should monitor the company’s ability to further reduce losses, improve cash flow generation, and manage credit risk in the coming year.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. Past performance is not indicative of future results. All information is based on the 2025 Annual Report of Luxxu Group Limited and is subject to change without notice.

View LUXXU GROUP Historical chart here